Genetic Alliance BioBank Logo
Registry and Biorepository Bulletin
Brought to you by Genetic Alliance BioBank
18 March 2010 Issue #1
Inaugural Issue of Registry and Biorepository Bulletin

Welcome to the inaugural issue of Registry and Biorepository Bulletin. This monthly newsletter will keep you informed of developments in the field of registries and biorepositories. We will highlight funding announcements, training opportunities, scientific meetings, and recent updates from the literature. We hope you enjoy this bulletin, and we look forward to your feedback.

Genetic Alliance to Offer $20,000 Grant to Join BioBank

Genetic Alliance's goal is to build capacity within the genetics community by being fluid, dynamic, and efficient: working to eliminate obstacles and limitations; and fostering innovation and collaboration. It is this spirit of building capacity and advancing novel partnerships that Genetic Alliance is offering one grant of $20,000, to be awarded to a single or multi-group organization or consortium towards the start-up fee for membership in the Genetic Alliance BioBank. Application deadline is May 1, 2010.

Click here for more information.

Tools and Training

Visit the new tools and training tab of the BioBank website. Here we have posted enduring materials from Registry and Repository Boot Camp, held January 10, 2010, and a virtual tour of Genetic Alliance BioBank software tools. We have also created a listserv to discuss issues surrounding registries and biorepositories.

Upcoming Meetings

The National Cancer Institute Office of Biorepositories and Biospecimen (OBBR) presents the 3rd Annual Biospecimen Research Network (BRN) Symposium: Advancing Cancer Research Through Biospecimen Science, March 24-25, Bethesda, MD.

The International Society for Biological and Environmental Repositories (ISBER) presents the 2010 Annual Meeting, Diversity in Biobanking: Embracing Differences, Harnessing Commonalities, May 11-15, Rotterdam, The Netherlands.


Edited by Liz Horn and Sharon Terry.

Please contact with questions or comments.

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 License.